Anti-FTSJ3 antibody - N-terminal,Abcam,AB186009

Host

Rabbit

Reactivity

Human

Application

IP

Platform ID

BAB623501249

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-FTSJ3 antibody - N-terminal
Cat. No.AB186009
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationIP
ClonalityPolyclonal
Concentration1 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Human FTSJ3 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: 99% Tris citrate/phosphate
Storage+4°C
Regulatory StatusResearch Use Only

Scientific Background

Target data RNA 2'-O-methyltransferase involved in the processing of the 34S pre-rRNA to 18S rRNA and in 40S ribosomal subunit formation.. (Microbial infection) In case of infection by HIV-1 virus, recruited to HIV-1 RNA and catalyzes 2'-O-methylation of the viral genome, allowing HIV-1 virus to escape the innate immune system (PubMed : 30626973). RNA 2'-O-methylation provides a molecular signature for discrimination of self from non-self and is used by HIV-1 to evade innate immune recognition by IFIH1/MDA5 (PubMed : 30626973). Mediates methylation of internal residues of HIV-1 RNA, with a strong preference for adenosine (PubMed : 30626973). Recruited to HIV-1 RNA via interaction with TARBP2/TRBP (PubMed : 30626973). See full target information FTSJ3

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.